{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:35:16Z","timestamp":1762004116298,"version":"build-2065373602"},"reference-count":94,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":5428,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.nurt.2008.07.002","type":"journal-article","created":{"date-parts":[[2008,10,4]],"date-time":"2008-10-04T15:11:21Z","timestamp":1223133081000},"page":"558-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["How Can We Treat Mitochondrial Encephalomyopathies? Approaches to Therapy"],"prefix":"10.1016","volume":"5","author":[{"given":"Rita","family":"Horvath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grainne","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick F.","family":"Chinnery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2008.07.002_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/WCO.0b013e3282ef58cd","article-title":"Mitochondrial disorders","volume":"20","author":"Zeviani","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nurt.2008.07.002_bib2","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1056\/NEJMra022567","article-title":"Mitochondrial respiratory-chain diseases","volume":"348","author":"DiMauro","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2008.07.002_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/9780470725207.ch15","article-title":"Mitochondrial mutations: genotype to phenotype","volume":"287","author":"Schon","year":"2007","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.nurt.2008.07.002_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10540-007-9041-4","article-title":"Mitochondrial diseases: therapeutic approaches","volume":"27","author":"DiMauro","year":"2007","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1016\/j.nurt.2008.07.002_bib5","article-title":"Treatment for mitochondrial disorders","author":"Chinnery","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nurt.2008.07.002_bib6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0960-8966(03)00097-X","article-title":"116th ENMC International Workshop: the treatment of mitochondrial disorders, 14th\u201316th March 2003, Naarden, The Netherlands","volume":"13","author":"Chinnery","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.07.002_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1472-6483(10)60494-4","article-title":"New approaches to the treatment of mitochondrial disorders","volume":"8","author":"Chinnery","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.nurt.2008.07.002_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1196\/annals.1293.023","article-title":"Mitochondrial encephalomyopathies: therapeutic approach","volume":"1011","author":"DiMauro","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nurt.2008.07.002_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/mus.20598","article-title":"Approaches to the treatment of mitochondrial diseases","volume":"34","author":"DiMauro","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.07.002_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.21217","article-title":"Prevalence of mitochondrial DNA disease in adults","volume":"63","author":"Schaefer","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.07.002_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ng0797-222","article-title":"Reversal of a mitochondrial DNA defect in human skeletal muscle","volume":"16","author":"Clark","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.nurt.2008.07.002_bib12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000117445","article-title":"Coenzyme Q10 treatment in mitochondrial encephalomyopathies: short-term double-blind, crossover study","volume":"37","author":"Chen","year":"1997","journal-title":"Eur Neurol"},{"issue":"Suppl","key":"10.1016\/j.nurt.2008.07.002_bib13","first-page":"442","article-title":"Coenzyme Q10 in ophthalmoplegia plus: a double blind cross over therapeutic trial","volume":"98","author":"Muller","year":"1990","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nurt.2008.07.002_bib14","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C","article-title":"A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies","volume":"20","author":"Tarnopolsky","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.07.002_bib15","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1212\/WNL.55.11.1748","article-title":"A placebo-controlled crossover trial of creatine in mitochondrial diseases","volume":"55","author":"Klopstock","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.07.002_bib16","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.45.6.1193","article-title":"Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders","volume":"45","author":"De Stefano","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.07.002_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1067\/mpd.2003.mpd0333","article-title":"The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: a double-blind randomized crossover clinical trial","volume":"142","author":"Liet","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.nurt.2008.07.002_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/01.wnl.0000196641.05913.27","article-title":"Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial","volume":"66","author":"Kaufmann","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.07.002_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1203\/00006450-199309000-00008","article-title":"Valproic acid impairs carnitine uptake in cultured human skin fibroblasts: an in vitro model for the pathogenesis of valproic acid-associated carnitine deficiency","volume":"34","author":"Tein","year":"1993","journal-title":"Pediatr Res"},{"key":"10.1016\/j.nurt.2008.07.002_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1034\/j.1600-0676.2000.020004346.x","article-title":"Mitochondrial disease represents a risk factor for valproate induced fulminant liver failure","volume":"20","author":"Kr\u00e4henb\u00fchl","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.nurt.2008.07.002_bib21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/01.jnen.0000229987.17548.6e","article-title":"POLG1 mutations associated with progressive encephalopathy in childhood","volume":"65","author":"Kollberg","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nurt.2008.07.002_bib22","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/brain\/awl097","article-title":"The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases","volume":"129","author":"Tzoulis","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.07.002_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1528-1167.2006.00454.x","article-title":"Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus","volume":"47","author":"Gibbs","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.nurt.2008.07.002_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1528-1167.2006.00906.x","article-title":"Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects","volume":"48","author":"Kang","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.nurt.2008.07.002_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(04)16983-3","article-title":"Parkinsonism, premature menopause, and mitochondrial DNA polymerase \u03b3 mutations: clinical and molecular genetic study","volume":"364","author":"Luoma","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nurt.2008.07.002_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/01.wnl.0000250334.48038.7a","article-title":"Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys","volume":"68","author":"Horvath","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.07.002_bib27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00129492-200305000-00012","article-title":"A review of cochlear implantation in mitochondrial sensorineural hearing loss","volume":"24","author":"Sinnathuray","year":"2003","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.nurt.2008.07.002_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ana.410430313","article-title":"Cochlear origin of hearing loss in MELAS syndrome","volume":"43","author":"Sue","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.07.002_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.nmd.2004.10.002","article-title":"Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders","volume":"15","author":"Yu Wai Man","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.07.002_bib30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/sj.eye.6701924","article-title":"Assessment of visual function in chronic progressive external ophthalmoplegia","volume":"20","author":"Yu Wai Man","year":"2006","journal-title":"Eye"},{"key":"10.1016\/j.nurt.2008.07.002_bib31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0161-6420(02)01009-6","article-title":"Management of myogenic ptosis","volume":"109","author":"Wong","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.nurt.2008.07.002_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00055735-199902000-00005","article-title":"Cataracts in systemic diseases and syndromes","volume":"10","author":"Hutnik","year":"1999","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.nurt.2008.07.002_bib33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.mito.2004.07.014","article-title":"Gastrointestinal complications of mitochondrial disease","volume":"4","author":"Hom","year":"2004","journal-title":"Mitochondrion"},{"key":"10.1016\/j.nurt.2008.07.002_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1262-3636(07)70105-2","article-title":"Mitochondrial Diabetes French Study Group","volume":"30","author":"Guillausseau","year":"2004","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.nurt.2008.07.002_bib35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0195-668X(02)00387-1","article-title":"Cardiomyopathy in children with mitochondrial disease: clinical course and cardiological findings","volume":"24","author":"Holmgren","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nurt.2008.07.002_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0195-668X(02)00694-2","article-title":"Mitochondria and the heart","volume":"24","author":"Bindoff","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nurt.2008.07.002_bib37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/heart.86.5.570","article-title":"Heart transplantation in children with mitochondrial cardiomyopathy","volume":"86","author":"Bonnet","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.nurt.2008.07.002_bib38","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.healun.2005.05.012","article-title":"Heart transplantation for progressive cardiomyopathy as a manifestation of MELAS syndrome","volume":"24","author":"Bhati","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.nurt.2008.07.002_bib39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1399-3046.2006.00629.x","article-title":"Successful cardiac transplantation in Barth syndrome: single-centre experience of four patients","volume":"11","author":"Mangat","year":"2007","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.nurt.2008.07.002_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0960-8966(01)00248-6","article-title":"Hypertrophic cardiomyopathy and mtDNA depletion: successful treatment with heart transplantation","volume":"12","author":"Santorelli","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2008.07.002_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.med.59.053006.104646","article-title":"Inherited mitochondrial diseases of DNA replication","volume":"59","author":"Copeland","year":"2008","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.nurt.2008.07.002_bib42","article-title":"Neurological phenotype is an important predictor of long term outcome in mitochondrial DNA depletion resulting from deoxyguanosine kinase deficiency","author":"Dimmock","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.nurt.2008.07.002_bib43","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/brain\/awl088","article-title":"Phenotypic spectrum associated with mutations of the mitochondrial polymerase \u03b3 gene","volume":"129","author":"Horvath","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.07.002_bib44","series-title":"Pediatric neurology: principles & practice","first-page":"494","article-title":"Mitochondrial diseases","author":"De Vivo","year":"1999"},{"key":"10.1016\/j.nurt.2008.07.002_bib45","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.283.5402.689","article-title":"Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder","volume":"283","author":"Nishino","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.nurt.2008.07.002_bib46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneur.64.3.435","article-title":"Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis","volume":"64","author":"Yavuz","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2008.07.002_bib47","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1212\/01.wnl.0000240853.97716.24","article-title":"Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE","volume":"67","author":"Hirano","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.07.002_bib48","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1172\/JCI31423","article-title":"Mutations in coenzyme Q10 biosynthetic genes","volume":"117","author":"DiMauro","year":"2007","journal-title":"J Clin Invest"},{"issue":"Suppl","key":"10.1016\/j.nurt.2008.07.002_bib49","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/j.mito.2007.03.008","article-title":"The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease","volume":"7","author":"Haas","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.nurt.2008.07.002_bib50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/biof.5520250113","article-title":"Clinical trials of coenzyme Q10 in neurological disorders","volume":"25","author":"Shults","year":"2005","journal-title":"Biofactors"},{"issue":"Suppl","key":"10.1016\/j.nurt.2008.07.002_bib51","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.mito.2007.02.007","article-title":"Mitochondrial targeting of quinones: therapeutic implications","volume":"7","author":"Cochem\u00e9","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.nurt.2008.07.002_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mito.2006.12.003","article-title":"Mitochondrial drug delivery and mitochondrial disease therapy: an approach to liposome-based delivery targeted to mitochondria","volume":"7","author":"Yamada","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.nurt.2008.07.002_bib53","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(00)02531-9","article-title":"Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency","volume":"356","author":"R\u00f6tig","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.nurt.2008.07.002_bib54","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ana.10371","article-title":"Coenzyme Q-responsive Leigh's encephalopathy in two sisters","volume":"52","author":"Van Maldergem","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.07.002_bib55","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/WNL.57.3.515","article-title":"Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency","volume":"57","author":"Di Giovanni","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.07.002_bib56","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1086\/500092","article-title":"A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency","volume":"78","author":"Quinzii","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nurt.2008.07.002_bib57","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1086\/510023","article-title":"Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations","volume":"79","author":"L\u00f3pez","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nurt.2008.07.002_bib58","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI29089","article-title":"Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders","volume":"117","author":"Mollet","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2008.07.002_bib59","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1096\/fj.07-100149","article-title":"Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency","volume":"22","author":"Quinzii","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.nurt.2008.07.002_bib60","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1212\/01.wnl.0000187070.35365.d7","article-title":"Tolerance of high-dose (3,000 mg\/day) coenzyme Q10 in ALS","volume":"65","author":"Ferrante","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.07.002_bib61","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/01.WNL.0000150588.75281.58","article-title":"Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation","volume":"64","author":"Quinzii","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.07.002_bib62","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajhg.2007.12.024","article-title":"ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency","volume":"82","author":"Lagier-Tourenne","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nurt.2008.07.002_bib63","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1212\/01.WNL.0000055089.39373.FC","article-title":"Cerebellar ataxia and coenzyme Q10 deficiency","volume":"60","author":"Lamperti","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.07.002_bib64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/01.wnl.0000194241.35115.7c","article-title":"Coenzyme Q10 deficiency may cause isolated myopathy","volume":"66","author":"Horvath","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.07.002_bib65","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/brain\/awm054","article-title":"The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene","volume":"130","author":"Gempel","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.07.002_bib66","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awm135","article-title":"ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"130","author":"Olsen","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.07.002_bib67","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","article-title":"Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomized, placebo-controlled trial","volume":"6","author":"Di Prospero","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nurt.2008.07.002_bib68","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ana.410190615","article-title":"Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study","volume":"19","author":"Argov","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.07.002_bib69","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1086\/316900","article-title":"Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene","volume":"67","author":"Keightley","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nurt.2008.07.002_bib70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/B:BOLI.0000016614.47380.2f","article-title":"Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper?","volume":"27","author":"Freisinger","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nurt.2008.07.002_bib71","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/hmg\/ddg192","article-title":"Mitochondrial DNA depletion can be prevented by dGMP and dAMP supplementation in a resting culture of deoxyguanosine kinase-deficient fibroblasts","volume":"12","author":"Taanman","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.07.002_bib72","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20624","article-title":"Mitochondria take center stage in aging and neurodegeneration","volume":"58","author":"Beal","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.07.002_bib73","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2741\/2130","article-title":"Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders","volume":"12","author":"Mancuso","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.nurt.2008.07.002_bib74","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mus.20688","article-title":"Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders","volume":"35","author":"Rodriguez","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.07.002_bib75","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ng0297-212","article-title":"Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids","volume":"15","author":"Taylor","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.nurt.2008.07.002_bib76","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.gt.3301061","article-title":"Peptide nucleic acid delivery to human mitochondria [Erratum in: Gene Ther 2000;7:813]","volume":"6","author":"Chinnery","year":"1999","journal-title":"Gene Ther"},{"key":"10.1016\/j.nurt.2008.07.002_bib77","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1093\/hmg\/ddh267","article-title":"Nuclear DNA-encoded tRNAs targeted into mitochondria can rescue a mitochondrial DNA mutation associated with the MERRF syndrome in cultured human cells","volume":"13","author":"Kolesnikova","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.07.002_bib78","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1074\/jbc.274.14.9386","article-title":"Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene","volume":"274","author":"Manfredi","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.07.002_bib79","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.20240","article-title":"Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells","volume":"56","author":"Santra","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.07.002_bib80","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuroscience.2006.11.065","article-title":"Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation","volume":"145","author":"Maalouf","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.nurt.2008.07.002_bib81","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/hmg\/8.6.1047","article-title":"Gene shifting: a novel therapy for mitochondrial myopathy","volume":"8","author":"Taivassalo","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2008.07.002_bib82","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/eye.1999.225","article-title":"Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns\u2013Sayre syndrome","volume":"13","author":"Andrews","year":"1999","journal-title":"Eye"},{"key":"10.1016\/j.nurt.2008.07.002_bib83","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/WNL.55.5.644","article-title":"Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA","volume":"55","author":"Karadimas","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.07.002_bib84","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10540-007-9042-3","article-title":"Experimental strategies towards treating mitochondrial DNA disorders","volume":"27","author":"Gardner","year":"2007","journal-title":"Biosci Rep"},{"key":"10.1016\/j.nurt.2008.07.002_bib85","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1093\/brain\/awl149","article-title":"Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy","volume":"129","author":"Jeppesen","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.07.002_bib86","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1093\/brain\/awl282","article-title":"Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions","volume":"129","author":"Taivassalo","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.07.002_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(06)68972-1","article-title":"Transmission of mitochondrial DNA disorders: possibilities for the future","volume":"368","author":"Brown","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.nurt.2008.07.002_bib88","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.theriogenology.2006.09.012","article-title":"Analysis of oocyte physiology to improve cryopreservation procedures","volume":"67","author":"Gardner","year":"2007","journal-title":"Theriogenology"},{"key":"10.1016\/j.nurt.2008.07.002_bib89","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1051\/medsci\/20052111987","article-title":"Prenatal and preimplantation genetic diagnosis: decision tree, new practices? [In French]","volume":"21","author":"Steffann","year":"2005","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/j.nurt.2008.07.002_bib90","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(05)62353-7","article-title":"Birth of infant after transfer of anucleate donor oocyte cytoplasm into recipient eggs","volume":"350","author":"Cohen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.nurt.2008.07.002_bib91","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/(SICI)1096-8628(19991126)87:3<265::AID-AJMG14>3.0.CO;2-S","article-title":"Prevention of human mitochondrial (mtDNA) disease by nucleus transplantation into an enucleated donor oocyte","volume":"87","author":"Roberts","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.nurt.2008.07.002_bib92","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.6857250","article-title":"Nuclear transplantation in the mouse embryo by microsurgery and cell fusion","volume":"220","author":"McGrath","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.nurt.2008.07.002_bib93","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1212\/01.wnl.0000219759.72195.41","article-title":"Mitochondrial disease in adults: a scale to monitor progression and treatment","volume":"66","author":"Schaefer","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.07.002_bib94","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.nmd.2006.08.006","article-title":"A scale to monitor progression and treatment of mitochondrial disease in children","volume":"16","author":"Phoenix","year":"2006","journal-title":"Neuromuscul Disord"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923004518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923004518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2008.07.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:37:58Z","timestamp":1761806278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923004518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1878747923004518"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2008.07.002","relation":{},"ISSN":["1878-7479"],"issn-type":[{"type":"print","value":"1878-7479"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How Can We Treat Mitochondrial Encephalomyopathies? Approaches to Therapy","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2008.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}